BOLT BIOTHERAPEUTICS, INC.

Profile

Company Names

BOLT BIOTHERAPEUTICS, INC.
BOLT THERAPEUTICS, INC.

Addresses

900 CHESAPEAKE DRIVE, REDWOOD CITY, CA 94063

640 GALVESTON DRIVE, REDWOOD CITY, CA 94063

640 GALVESTON DR., REDWOOD CITY, CA 94063

1556 RUBINO COURT, PLEASANTON, CA 94566

Phone Numbers

650-665-9295
650.665.9295
310-909-3218

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER, OTHER TECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$178,589,146.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2021-06-01 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
6
2020-06-26 
$93,499,984.00 
$93,499,984.00 
$0.00 
Equity 
5
2019-07-01 
$40,103,799.00 
$40,103,799.00 
$0.00 
Equity 
4
2018-07-26 
$13,385,363.00 
$13,385,363.00 
$0.00 
Equity 
3
2018-02-14 
$6,000,002.00 
$6,000,002.00 
$0.00 
Equity 
2
2016-09-21 
$9,999,998.00 
$15,999,999.00 
$6,000,001.00 
Equity 
1
2015-05-04 
$600,000.00 
$800,000.00 
$200,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PETER 
 
BISGAARD 
DIRECTOR
M2 GROUP HOLDINGS INC   |  LIGHT SCIENCES ONCOLOGY INC   |  OTONOMY, INC.   |  HIGH THROUGHPUT GENOMICS INC   |  HTG MOLECULAR DIAGNOSTICS INC   |  ALTHEOS, INC.   |  THESAN PHARMACEUTICALS, INC.   |  CETERIX ORTHOPAEDICS, INC.   |  HTG MOLECULAR DIAGNOSTICS, INC   |  RA PHARMACEUTICALS, INC.   |  OUTPOST MEDICINE, LLC   |  BOLT BIOTHERAPEUTICS, INC.   |  EARGO, INC.   |  ONCXERNA THERAPEUTICS, LTD.   |  MAPLIGHT THERAPEUTICS, INC.   |  ADDITION THERAPEUTICS, INC.
DAVID 
 
DORNAN 
EXECUTIVE OFFICER
BOLT BIOTHERAPEUTICS, INC.   |  AADI BIOSCIENCE, INC.
EDGAR 
 
ENGLEMAN 
DIRECTOR, EXECUTIVE OFFICER
CAPNIA, INC.   |  VIVO VENTURES VII AFFILIATES FUND, L.P.   |  SEMNUR PHARMACEUTICALS, INC.   |  VIVO CAPITAL FUND VIII, L.P.   |  VIVO CAPITAL SURPLUS FUND VIII, L.P.   |  VIVO CAPITAL FUND IX, L.P.   |  BOLT BIOTHERAPEUTICS, INC.   |  VIVO INNOVATION FUND II, L.P.   |  VIVO CAPITAL FUND X, L.P.
EDGAR 
G 
ENGLEMAN 
DIRECTOR
SYNAPSE BIOMEDICAL INC   |  BOLT THERAPEUTICS, INC.
EDGAR 
G. 
ENGLEMAN 
EXECUTIVE OFFICER, DIRECTOR
CAPNIA, INC.   |  EIGER BIOPHARMACEUTICALS, INC.   |  BOLT BIOTHERAPEUTICS, INC.   |  SOLENO THERAPEUTICS INC
KEN 
 
HARRISON 
DIRECTOR
BOLT BIOTHERAPEUTICS, INC.
JAMES 
 
HEALY 
DIRECTOR
GFP MANAGED EQUITIES I LP   |  DXTERITY DIAGNOSTICS INC   |  SORBENT THERAPEUTICS INC   |  HYPERION THERAPEUTICS INC   |  DFMSIM INC   |  SOFINNOVA VENTURE PARTNERS VIII, L.P.   |  KALOBIOS PHARMACEUTICALS INC   |  GRAN PARADISO CAPITAL PARTNERS, LLC   |  ASCENDIS PHARMA A/S   |  CAPRA IBEX CLO INVESTOR, LLC   |  BOLT BIOTHERAPEUTICS, INC.   |  SOFINNOVA SYNERGY MASTER FUND, LP   |  ARRIVENT BIOPHARMA, INC.   |  ATSENA THERAPEUTICS, INC.   |  BIOAGE LABS, INC.
ASHISH 
 
KHANNA 
DIRECTOR
NAUREX INC.   |  SUTROVAX, INC.   |  APTINYX INC.   |  BOLT BIOTHERAPEUTICS, INC.   |  FOUNTAIN THERAPEUTICS, INC.
KATHLEEN 
 
LAPORTE 
DIRECTOR
AFFYMAX INC   |  BOLT BIOTHERAPEUTICS, INC.   |  CERO THERAPEUTICS HOLDINGS, INC.
REINER 
 
LAUS 
EXECUTIVE OFFICER, DIRECTOR
BOLT BIOTHERAPEUTICS, INC.   |  TRIO PHARMACEUTICALS, INC.
CHIH-PING 
 
LIU 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
BOLT THERAPEUTICS, INC.   |  NEUROCEA LLC   |  ANGARUS THERAPEUTICS, INC.
RICHARD 
 
MILLER 
DIRECTOR
IFLI ACQUISITION CORP.   |  ESANEX, INC.   |  SIMPLEPONS, INC.   |  OPINIONLAB, INC.   |  OPENTEMPO, INC.   |  TCW DIRECT LENDING STRATEGIC VENTURES LLC   |  TCW SPECIALTY LENDING FUND, L.P.   |  NJ/TCW DIRECT LENDING LLC   |  EXP WORLD HOLDINGS, INC.   |  HARDYWOOD PARK CRAFT BREWERY, LLC   |  SEIKOWAVE DENTAL, INC.   |  OMNITEK ENGINEERING CORP   |  BOLT BIOTHERAPEUTICS, INC.   |  SEIKOWAVE HEALTH SOLUTIONS, INC.   |  OXFORD BANK CORP   |  IDION, INC.   |  ADB HOLDINGS GROUP, LP   |  WUUNDERFUND, INC
PETER 
 
MOLDT 
DIRECTOR
CARDEAS PHARMA CORP   |  ALLAKOS INC.   |  BIOCLIN THERAPEUTICS, INC.   |  CORVUS PHARMACEUTICALS, INC.   |  VASCULOX, INC.   |  E-SCAPE BIO, INC.   |  TIOMA THERAPEUTICS, INC.   |  BOLT BIOTHERAPEUTICS, INC.   |  VIEWPOINT THERAPEUTICS, INC.   |  OUTPOST MEDICINE, LLC   |  SWIFT HEALTH SYSTEMS INC.   |  ALIGOS THERAPEUTICS, INC.   |  ESCAPE BIO, INC.   |  AVALYN PHARMA INC.
EDITH 
 
PEREZ 
EXECUTIVE OFFICER
BOLT BIOTHERAPEUTICS, INC.
WILLIAM 
 
QUINN 
EXECUTIVE OFFICER
ASTRO AB HOLDINGS, LLC   |  PEARL ENERGY INVESTMENTS II, L.P.   |  PEARL RW HOLDINGS, L.P.   |  BOLT BIOTHERAPEUTICS, INC.   |  VICTORY INVESTMENT PARTNERS, L.P.   |  PEARL ENERGY INVESTMENTS III, L.P.   |  PEARL NFF INVESTMENTS III, L.P.   |  PEARL INR HOLDINGS, L.P.   |  PEARL INR HOLDINGS-A, L.P.   |  INFINITY NATURAL RESOURCES, INC.
RANDALL 
 
SCHATZMAN 
EXECUTIVE OFFICER, DIRECTOR
ALDER BIOPHARMACEUTICALS INC   |  BOLT BIOTHERAPEUTICS, INC.
MAHENDRA 
 
SHAH 
DIRECTOR
AVADHI FINANCE + TECHNOLOGY INC   |  CRINETICS PHARMACEUTICALS, INC.   |  VIVO PANDA FUND, L.P.   |  BOLT BIOTHERAPEUTICS, INC.   |  IMPEL NEUROPHARMA INC   |  HOMOLOGY MEDICINES, INC.   |  SOLENO THERAPEUTICS INC   |  CEREBRAL THERAPEUTICS, INC.   |  VERONA PHARMA PLC   |  SCIENTIA VASCULAR, INC.
GRANT 
 
YONEHIRO 
EXECUTIVE OFFICER
BOLT BIOTHERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-06-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-06-01 
2021-01-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-06-26 
2019-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
2018-08-06
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-26 
2018-02-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-14 
2016-09-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-21 
2015-05-07
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#